Dr Kitty St Pierre
Lecturer
School of Pharmacy and Pharmaceutical Sciences
Researcher biography
Dr Kitty St Pierre is a Lecturer within the School of Pharmacy and Pharmaceutical Sciences, and a Senior Research Pharmacist with Queensland Health. Her research interests include clinical pharmacy and medication management, particularly in the fields of kidney disease and stroke.
Book Chapter
St Pierre, Kitty I., Hill, Katherine and Staatz, Christine E. (2025). Considering kidney and liver function when prescribing and reviewing medicines in older people. Polypharmacy and geriatrics. (pp. 207-229) edited by Nagham J. Ailabouni. Cham, Switzerland: Springer Cham. doi: 10.1007/978-3-031-77314-3_8
Journal Articles
Abdy, Mia E., St Pierre, Kitty, Major, Emily, Alexander, Stephen I., Cashmore, Brydee, Coolican, Helen, Cullen, Vanessa, Dawson, Jessica, Lambert, Kelly, Lee, Vincent W., Mallawaarachi, Amali, Rangan, Gopala, Savige, Judy, Varughese, Santosh, Tunnicliffe, David J., Mallett, Andrew J. and the CARI Guidelines Steering Committee (2026). Caring for Australians and
New ZealandeRs
with kidney
Impairment
guideline commentary on kidney disease: improving global outcomes 2025 guidelines for diagnosis and management of autosomal polycystic kidney disease. Internal Medicine Journal imj.70411. doi: 10.1111/imj.70411
Lim, Ru Sin, Ma, Becky Mingyao, St Pierre, Kitty, Biros, Erik and Mallett, Andrew J. (2026). Autosomal Dominant Polycystic Kidney Disease: Genetic Insights, Phenotypic Spectrum, and Advances in Prognosis and Treatment. Advances in Kidney Disease and Health, 33 (1), 15-26. doi: 10.1053/j.akdh.2025.12.003
Olsen, William Manning, St Pierre, Kitty, Thompson, Wade, Weir, Kristie Rebecca, Freeman, Christopher Robert, Bohill, Ruth, Farrell, Barbara, Langford, Aili Veronica, O'Donnell, Lisa Kouladjian, Reeve, Emily, Liau, Shin J, McEvoy, Aisling Mary, Shrestha, Shakti, Tesfaye, Wubshet, Breen, Juanita, Etherton-Beer, Christopher, Yik, Jerry, Turner, Justin and Ailabouni, Nagham J. (2026). Shaping future deprescribing priorities: outcomes of a World Café stakeholder workshop. Expert review of clinical pharmacology, 19 (1), 85-96. doi: 10.1080/17512433.2025.2609659
St Pierre, Kitty, El-Damanawi, Ragada, Jefferis, Julia, Johnson, David W., Hawley, Carmel M., Staatz, Christine E., Viecelli, Andrea K. and Mallett, Andrew J. (2025). Endpoint selection in autosomal dominant polycystic kidney disease clinical trials. Kidney International Reports, 10 (11), 3773-3784. doi: 10.1016/j.ekir.2025.09.024
St Pierre, Kitty, Cashmore, Brydee, Cumpston, Miranda S., Hill, Kelvin, McDonald, Steve, Pattuwage, Loyal, White, Heath, Whittle, Samuel L., Turner, Tari and Tunnicliffe, David J. (2025). Methods for living guidelines: Paper 6: Insights from ALEC’s use of existing systematic reviews in living guideline development. Journal of Clinical Epidemiology, 187 111812, 1-13. doi: 10.1016/j.jclinepi.2025.111812
St Pierre, Kitty, El-Damanawi, Ragada, Johnson, David W., Hawley, Carmel M., Viecelli, Andrea K., Jha, Vivekanand, Green, Suetonia C., Gesualdo, Loreto, Kiriwandeniya, Charani, Velayudham, Pushparaj, Vergara, Liza A., Mihala, Gabor, Matsuyama, Misa, Brent, Peta-Ann Paul, Mallett, Andrew J. and IMPEDE-PKD Global Steering Committee (2025). Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease. Trials, 26 (1) 302. doi: 10.1186/s13063-025-09010-6
St Pierre, Kitty, Cashmore, Brydee A, Bolignano, Davide, Zoccali, Carmine, Ruospo, Marinella, Craig, Jonathan C, Strippoli, Giovanni FM, Mallett, Andrew J, Green, Suetonia C and Tunnicliffe, David J (2024). Interventions for preventing the progression of autosomal dominant polycystic kidney disease. Cochrane Database of Systematic Reviews, 2024 (10) CD010294, CD010294-10. doi: 10.1002/14651858.CD010294.pub3
El-Damanawi, Ragada, Stanley, Isabelle Kitty, Staatz, Christine, Pascoe, Elaine M., Craig, Jonathan C., Johnson, David W., Mallett, Andrew J., Hawley, Carmel M., Milanzi, Elasma, Hiemstra, Thomas F. and Viecelli, Andrea K. (2024). Metformin for preventing the progression of chronic kidney disease. Cochrane Database of Systematic Reviews, 2024 (6) CD013414, CD013414. doi: 10.1002/14651858.cd013414.pub2
Stanley, I. Kitty, Palma, Anton M., Viecelli, Andrea K., Johnson, David W., Hawley, Carmel M., Staatz, Christine E. and Mallett, Andrew J. (2024). A secondary analysis of concurrent use of metformin and tolvaptan in ADPKD tolvaptan trials. Journal of Nephrology, 37 (5), 1417-1419. doi: 10.1007/s40620-024-01906-x
Stanley, Kitty, Mallett, Andrew J., Viecelli, Andrea K., Hawley, Carmel M., Staatz, Christine E., Johnson, David W. and Milanzi, Elasma (2024). A post hoc analysis of the CKD-FIX study analysing the association between metformin usage and eGFR decline. Kidney International Reports, 9 (5), 1525-1527. doi: 10.1016/j.ekir.2024.02.011
Stanley, Isabelle Kitty, Phoon, Richard K. S., Toussain, Nigel D., Cullen, Vanessa, Kearns, John, Dalbeth, Nicola, Johnson, David W., Krishnasamy, Rathika and Tunnicliffe, David J. (2022). Caring for Australians and New Zealanders With Kidney Impairment guidelines: rapid development of urate lowering therapy guidelines for people with CKD. Kidney International Reports, 7 (12), 2563-2574. doi: 10.1016/j.ekir.2022.09.024
Stanley, Isabelle Kitty, Schultz, Kadin L., Gardiner, Kyle M. and Staatz, Christine E. (2021). Evaluating the utilisation and expenditure patterns of erythropoietin stimulating agents and immunosuppressants in Australian chronic kidney disease patients. Journal of Pharmaceutical Health Services Research, 12 (3), 350-356. doi: 10.1093/jphsr/rmab027
Conference Papers
Stanley, I., Viecelli, A., Johnson, D., Hawley, C., Mallett, A., Staatz, C. and Milanzi, E. (2023). A post-hoc analysis of the CKD-FIX study analysing the association between metformin use and eGFR decline. Australian and New Zealand Society of Nephrology Conference, Cairns, QLD, Australia, 22-24 October 2023. HOBOKEN: WILEY.
Stanley, I., Palma, A., Viecelli, A., Johnson. D., Hawley, C., Staatz, C. and Mallett, A. (2023). A Secondary Analysis of Concurrent use of Metformin and Tolvaptan in ADPKD Tolvaptan Trials. Asian Pacific Society of Dialysis Access (APSDA) Conference, Cairns, QLD Australia, 22-24th October 2023. HOBOKEN: WILEY.
Thesis
St Pierre, Kitty (2025). Establishing the role of metformin for ADPKD through therapeutic investigation and guideline development. PhD Thesis, Faculty of Medicine, The University of Queensland. doi: 10.14264/b82c120